ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease

Jeffrey W. Olin, David E. Allie, Michael Belkin, Robert O. Bonow, Donald E. Casey, Mark A. Creager, Thomas C. Gerber, Alan T. Hirsch, Michael R. Jaff, John A. Kaufman, Curtis A. Lewis, Edward T. Martin, Louis G. Martin, Peter Sheehan, Kerry J. Stewart, Diane Treat-Jacobson, Christopher J. White, Zhi Jie Zheng

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations
Original languageEnglish (US)
Pages (from-to)2147-2181
Number of pages35
JournalJournal of the American College of Cardiology
Volume56
Issue number25
DOIs
StatePublished - Dec 14 2010

Bibliographical note

Funding Information:
Committee Member Employer/Title Consultant Speaker Ownership/Partnership/Principal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Jeffrey W. Olin (Chair) Mt. Sinai School of Medicine/Director, Vascular Medicine Program • Bristol-Myers Squibb/Sanofi Genzyme Schering-Plough Takeda • • • None None • Genzyme Sanofi • None • Cleveland Clinic Foundation Johnson & Johnson ⁎ • David E. Allie Cardiovascular Institute of the South—Lafayette/Chief of Cardiothoracic and Endovascular Surgery • ev3 Flowmedica Spectranetics Toshiba/Bracco ⁎ • ⁎ • ⁎ • ⁎ • Spectranetics None None None None Michael Belkin Brigham and Women's Hospital, Harvard Medical School/Vascular Surgery Fellowship Program Director • Aastrom Biosciences, Inc. • AGA Medical None Merck None None None Robert O. Bonow Northwestern University Feinberg School of Medicine/Goldberg Distinguished Professor; Chief, Division of Cardiology None • Edwards Lifesciences ⁎ None None None None Donald E. Casey Atlantic Health/Vice President, Quality and Chief Medical Officer None None None None None None Mark A. Creager Brigham and Women's Hospital Cardiovascular Division/Professor of Medicine (Cardiology) • ActivBiotics • Biomarin • Genzyme • Kos Pharmacuticals • Sanofi-Aventis • Sigma Tau • Bristol-Myers Squibb • Merck • Sanofi-Aventis None None Thomas C. Gerber Mayo College of Medicine, Mayo Clinic Division of Cardiovascular Diseases/Associate Professor of Medicine and Radiology None None None None None None Alan T. Hirsch University of Minnesota School of Public Health/Professor of Epidemiology and Community Health • Kos Pharmaceuticals Pifzer Roche • ⁎ • ⁎ • Bristol-Myers Squibb/Sanofi-Aventis None • Abbott Vascular AstraZeneca Bristol-Myers Squibb/Sanofi-Aventis Kos Pharmaceuticals Omron PreMD SonoSite • • • ⁎ • • • None None Michael R. Jaff Massachusetts General Hospital/Director, Vascular Diagnostic Lab • Abbott Vascular • Arsenal Medical • Atheromed • Bacchus Vascular • Baxter Healthcare • Boston Scientific • Cortis • FlexStent • HCRI ⁎ • Hypermed • I.C. Sciences • Medical Simulation Corporation • Medtronic • Micell • Nexeon MedSystems • Pathway Medical • Proteon • Takeda Pharmaceuticals None None • Access Closire • Icon Interventional • Sadra Medical • Setagon • Square One • Vascular Therapies • VIVA Physicians, Inc. ⁎ None John A. Kaufman Dotter Interventional Institute Oregon Health and Science University/Professor of Radiology None None None None None None Curtis A. Lewis The Grady Health System/Chief of Staff and Sr. Vice President of Medical Affairs None None None None None None Edward T. Martin Oklahoma Heart Institute/Director, Cardiovascular MRI Center • Astellas • Siemens • GE Healthcare ⁎ None • Siemens • Astellas • Siemens None Louis G. Martin Emory University School of Medicine/ Professor, Department of Radiology None None None None None None Peter Sheehan Mount Sinai School of Medicine/Senior Faculty None • Bristol-Myers Squibb/Sanofi Edwards Lifesciences FoxHollow ⁎ • ⁎ • ⁎ None • Genzyme ⁎ • Nissan ⁎ None None Kerry J. Stewart Johns Hopkins University School of Medicine Johns Hopkins Bayview Medical Center/Professor of Medicine and Director, Clinical and Research Exercise Physiology None None None None None None Diane Treat-Jacobson University of Minnesota School of Nursing/Assistant Professor • Kos Pharmacuticals ⁎ • Bristol-Myers Squibb/Sanofi-Aventis None • National Heart, Lung, and Blood Institute ⁎ None None Christopher J. White Ochsner Clinic Foundation/Chairman, Department of Cardiology None • Baxter Boston Scientific • None None None None Zhi-Jie Zheng Center for the Application of Research Discoveries National Heart, Lung and Blood Institute/Senior Medical Epidemiologist None None None None None None This table represents the relationships of committee members with industry and other entities that were reported by authors to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document-development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, if the interest represents ownership of $10 000 or more of the fair market value of the business entity. or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted. ⁎ Significant relationship. Appendix B

Funding Information:
Reviewer Representation Consultant Speaker Ownership/Partnership/Principal Personal Research Institutional, Organizational or Other Financial Benefit Expert Witness Herbert Aronow Official Reviewer—SVM • Cordis • Medtronic • Bristol-Myers Squibb/Sanofi-Aventis • Pfizer ⁎ None None None None Robert M. Bersin Official Reviewer—SCAI • Abbott Vascular ⁎ • Boston Scientific ⁎ • Bristol-Myers Squibb • Cordis Endovascular ⁎ • Daiichi Sankyo • Eli Lilly • ev3 ⁎ • Medtronic Vascular • Palmaz Scientific • ReVascular Therapeutics • Sanofi-Aventis • Vascular Solutions • W.L. Gore ⁎ • Boston Scientific ⁎ • Bristol-Myers Squibb • Cordis Endovascular ⁎ • Daiichi Sankyo • Eli Lilly • The Medicines Co. • Sanofi-Aventis • Boston Scientific ⁎ • Cordis Endovascular ⁎ None None None Alain T. Drooz Official Reviewer—SIR • Possis Medical • Peripheral Angioplasty & All that Jazz – May 2007 None • Invatec INTENSE Trial DSMB None None Gordon Fung Official Reviewer—ACCF Board of Governors None • Abbott Cardiovascular • GlaxoSmithKline None • Roche Pharmaceuticals • AHA/LWW • UCSF(Vice Chair, Committee on Human Research) • UCSF School of Medicine (Director, Clinical Faculty Affairs) None Bertrand Janne d'Othee Official Reviewer—ACR None None None None None None Debra Kohlman-Trigoboff Official Reviewer—SVN None None None None None None Sanjoy Kundu Official Reviewer—SIR None None None None None None Frank W. LoGerfo Official Reviewer—SVS None None None None None None James O. Menzoian Official Reviewer—SVS None None None None None None Sanjay Misra Official Reviewer—AHA None None None • National Center for Research Resources (part of NIH) ⁎ None None Issam Moussa Official Reviewer—SCAI None None None None None None Martha J. Radford Official Reviewer—ACCF/AHA Task Force on Performance Measures Lead Reviewer None None None None None None Anne C. Roberts Official Reviewer—AHA and ACR None None None None • ACR Board of Chancellors None George P. Rodgers Official Reviewer—ACCF Board of Trustees • United Health None • Biophysical ⁎ None • Paragon Health • For defendent (injury on treadmill) Nakela Cook Organizational Reviewer—NHLBI None None None None None None Ricardo C. Cury Organizational Reviewer—SCCT • Astellas Pharma • Siemens None • Astellas Pharma ⁎ • Pfizer Inc. ⁎ • SCCT Board Member None James M. Galloway Organizational Reviewer—ADA None None None None None None Jerry Goldstone Organizational Reviewer—PAD Coalition • Vascutek, a TERUMO company None None None None None Marjorie L. King Organizational Reviewer—AACVPR None None None None None None M. Sue Kirkman Organizational Reviewer—ADA None None None None None None Christopher Kramer Organizational Reviewer—SAIP • Siemens Medical Solutions • Merck • Schering-Plough None • Astellas ⁎ • GlaxoSmithKline ⁎ • Siemens Medical Solutions ⁎ None None John R. Lesser Organizational Reviewer—SCCT • Vital Images • Siemens Medical Solutions None None None None Keith Michl Organizational Reviewer—ACP None None None None None None Diane Reid Organizational Reviewer—NHLBI None None None None None None Carolyn Robinson Organizational Reviewer—PAD Coalition None None None None None None Frank Rybicki Organizational Reviewer—SCMR None • Vital Images None • Bracco Diagnostics • Toshiba Medical Systems None None Ray Squires Organizational Reviewer—AACVPR None None None None None None Allen Taylor Organizational Reviewer—SAIP None • Abbott ⁎ None • Abbott None None Steven D. Wolff Organizational Reviewer—SCMR • GE Healthcare ⁎ None • NeoCoil, LLC • NeoSoft, LLC None None None Elizabeth Delong Content Reviewer—ACCF/AHA Task Force on Performance Measures None None None None None None Kathleen Grady Content Reviewer—ACCF/AHA Task Force on Performance Measures None None None None None None Hitinger Gurm Content Reviewer—ACCF Peripheral Vascular Disease Committee • Icon Interventional Systems None None • Blue Cross Blue Shield of Michigan ⁎ None None William Hiatt Content Reviewer—Individual None None None • Bristol-Myers Squibb/Sanofi-Aventis ⁎ • Otsuka Japan ⁎ None None Loren F. Hiratzka Content Reviewer—ACC/AHA 2005 PAD Clinical Practice Guideline Writing Committee None • AHA None None None None David J. Malenka Content Reviewer—ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS PAVD Data Standards Writing Committee None None None • Abbott Vascular ⁎ • St. Jude Medical Foundation ⁎ None None Richard Milani Content Reviewer—Individual None • Astra-Zeneca • Bristol-Myers Squibb ⁎ • Pfizer • Sanofi-Aventis None None None • For plaintiff (suit alleging owners of boat-diving company failed to provide timely medical care for a passenger who suffered acute MI) Timothy Murphy Content Reviewer—Individual • Bristol-Myers Squibb ⁎ None None • Abbott Vascular ⁎ • Boston Scientific ⁎ • Cordis/Johnson & Johnson ⁎ • Otsuka Pharmaceuticals ⁎ None None This table represents the relevant relationships with industry and other entities that were disclosed by reviewers at the time of peer review. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, if the interest represents ownership of $10 000 or more of the fair market value of the business entity, or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review. Participation in the peer review process does not imply endorsement of this document. ACC indicates American College of Cardiology; ACCF, American College of Cardiology Foundation; ACR, American College of Radiology; AHA, American Heart Association; DSMB, data safety monitoring board; LWW, Lippincott, Williams, & Wilkins; NHLBI, National, Heart, Lung, and Blood Institute; NIH, National Institutes of Health; PAD, peripheral arterial disease; PAVD, peripheral atherosclerotic vascular disease; SCAI, Society for Cardiac Angiography and Interventions; SCCT, Society of Cardiovascular Computed Tomography; SIR, Society of Interventional Radiology; STS, Society of Thoracic Surgeons; SVM, Society for Vascular Medicine; SVN, Society of Vascular Nursing; SVS, Society for Vascular Surgery; and UCSF, University of California, San Francisco. ⁎ Significant relationship. Appendix C

Cite this